Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Larimar Therapeutics, Inc.

NASDAQ: LRMR · Life Sciences · 10 alerts · CIK 1374690

Share price
$3.00Close, Nov 16
Market cap
$314M
Shares outstanding
104.63MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Larimar Therapeutics, Inc. filings on SEC EDGAR ↗

9:32 PM ET Form 4
Insider Buying

Larimar Therapeutics Director Thomas Edward Hamilton Buys $187K of Stock

Thomas Edward Hamilton, Director, bought 70,000 shares of Larimar Therapeutics, Inc. at $2.67 a share, worth $187K in total on Nov 12, 2026. Shares held after the trade: 70,000.

Value
$187K
Shares
70,000
Price
$2.67
Role
Director
Trade date
Nov 12, 2026
6:03 PM ET Form 4
Insider Buying

Larimar Therapeutics President and CEO Carole Ben-maimon Buys $50K of Stock

Carole Ben-maimon, President and CEO, bought 18,050 shares of Larimar Therapeutics, Inc. at $2.77 a share, worth $50K in total on Nov 11, 2026. Shares held after the trade: 386,326 (+4.9%).

Value
$50K
Shares
18,050
Price
$2.77
Role
President and CEO
Holding change
+4.9%
Trade date
Nov 11, 2026
6:01 PM ET Form 4
Insider Buying

Larimar Therapeutics Director Frank E. Thomas Buys $21.8K of Stock

Frank E. Thomas, Director, bought 8,000 shares of Larimar Therapeutics, Inc. at $2.73 a share, worth $21.8K in total on Nov 11, 2026. Shares held after the trade: 15,000 (+114.3%).

Value
$21.8K
Shares
8,000
Price
$2.73
Role
Director
Holding change
+114.3%
Trade date
Nov 11, 2026
6:00 PM ET Form 4
Insider Buying

Larimar Therapeutics President and COO John B. Harlow Jr. Buys $49.9K of Stock

John B. Harlow Jr., President and COO, bought 17,800 shares of Larimar Therapeutics, Inc. at $2.80 a share, worth $49.9K in total on Nov 11, 2026. Shares held after the trade: 67,800 (+35.6%).

Value
$49.9K
Shares
17,800
Price
$2.80
Role
President and COO
Holding change
+35.6%
Trade date
Nov 11, 2026
5:57 PM ET Form 4
Insider Buying

Larimar Therapeutics CFO Michael Celano Buys $50K of Stock

Michael Celano, CFO, bought 18,460 shares of Larimar Therapeutics, Inc. at $2.71 a share, worth $50K in total on Nov 11, 2026. Shares held after the trade: 234,245 (+8.6%).

Value
$50K
Shares
18,460
Price
$2.71
Role
CFO
Holding change
+8.6%
Trade date
Nov 11, 2026
5:55 PM ET Form 4
Insider Buying

Larimar Therapeutics Chief Development Officer Gopi Shankar Buys $13.5K of Stock

Gopi Shankar, Chief Development Officer, bought 5,000 shares of Larimar Therapeutics, Inc. at $2.71 a share, worth $13.5K in total on Nov 11, 2026. Shares held after the trade: 81,443 (+6.5%).

Value
$13.5K
Shares
5,000
Price
$2.71
Role
Chief Development Officer
Holding change
+6.5%
Trade date
Nov 11, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.